REGULUS THERAPEUTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2 USD | 0.00% |
|
-9.50% | +56.25% |
Chart calendar Regulus Therapeutics Inc.
22de2c37529d3fa0ee6dad.Vde9KA_ao0W5vrFNB_zq2YIWgbkQEEdYBqPULZBFWmk.IrXJcXvu5CLYhtd8baiDuttCxvx0ZyQ6V-aGGcMWPAYQoOlfVe7zBM7KgQ~26648ace0808300811603a4bc2510d01
Upcoming events on Regulus Therapeutics Inc.
Past events on Regulus Therapeutics Inc.
| 2024-05-16 12:00 pm | Annual General Meeting |
| 2024-05-09 04:05 pm | Q1 2024 Earnings Release |
| 2024-05-01 01:00 pm | Canaccord Genuity Genetic Medicine for Generalists Webcast Series |
| 2024-03-21 04:05 pm | Q4 2023 Earnings Release |
| 2024-03-12 08:30 am | Business Update Call |
| 2024-01-04 | Investor Meeting After hours |
| 2023-11-29 10:25 am | Evercore ISI HealthCONx Conference |
| 2023-11-09 04:05 pm | Q3 2023 Earnings Release |
| 2023-09-20 08:30 am | RGLS8429 Phase 1b Study Results Call |
| 2023-09-11 11:00 am | H.C. Wainwright Global Investment Conference |
| 2023-09-06 11:00 am | R&D Day |
| 2023-09-05 | Wells Fargo Healthcare Conference |
| 2023-08-09 11:30 am | Canaccord Genuity Growth Conference |
| 2023-08-08 04:05 pm | Q2 2023 Earnings Release |
| 2023-07-25 03:00 pm | H.C. Wainwright Kidney Conference |
| 2023-06-01 12:00 pm | Annual General Meeting |
| 2023-05-11 04:05 pm | Q1 2023 Earnings Release |
| 2023-03-23 04:05 pm | Q4 2022 Earnings Release |
| 2023-03-08 | Chronic Kidney Disease Drug Development Summit |
| 2023-02-16 01:00 pm | SVB Securities Global Biopharma Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 6,83 6,86 -0.38% | 10,0 5,02 99.28% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -30,9 -30,7 -0.59% | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -16,8 -17,2 2.18% | -14,2 -19,2 26.36% | -27,8 -27,4 -1.42% | -28,2 -28,9 2.15% | -31,1 -30,9 -0.82% | -36,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -18,6 -18,9 1.85% | -15,7 -20,9 24.88% | -27,8 -26,9 -3.43% | -28,3 -29,1 2.67% | -30,0 -29,9 -0.47% | -35,2 |
|
Net income Million USD | Released Forecast Spread | -18,6 -18,9 1.85% | -15,7 -20,9 24.86% | -27,8 -26,9 -3.43% | -28,3 -29,1 2.67% | -30,0 -30,0 -0.13% | -34,5 |
|
EPS USD | Released Forecast Spread | -10,8 -11,0 1.82% | -4,50 -6,60 31.82% | -3,20 -3,27 2.04% | -1,86 -1,83 -1.82% | -1,58 -1,59 0.32% | -0,61 |
| Announcement Date | 12/03/20 | 09/03/21 | 10/03/22 | 23/03/23 | 21/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -6,57 -7,21 8.84% | -7,18 -7,05 -1.77% | -7,56 -7,35 -2.9% | -6,93 -7,66 9.5% | -7,37 -7,08 -4.16% | -7,32 -7,51 2.55% | -8,13 -7,51 -8.19% | -8,30 -8,05 -3.11% | -8,83 -8,70 -1.45% | -8,90 | -9,43 | -9,43 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,72 -7,20 6.75% | -7,26 -7,14 -1.67% | -7,55 -7,39 -2.13% | -6,80 -7,70 11.75% | -7,14 -6,99 -2.1% | -7,01 -7,34 4.41% | -7,82 -7,31 -6.99% | -8,06 -7,91 -1.94% | -8,47 -8,56 1.05% | -8,54 | -9,08 | -9,09 | ||
|
Net income Million USD | Released Forecast Spread | -6,72 -7,20 6.73% | -7,26 -7,14 -1.67% | -7,55 -7,39 -2.13% | -6,80 -7,70 11.75% | -7,14 -6,99 -2.1% | -7,01 -7,34 4.39% | -7,82 -7,31 -6.99% | -8,06 -8,01 -0.7% | -8,47 -8,07 -4.91% | -8,36 | -8,79 | -8,82 | ||
|
EPS USD | Released Forecast Spread | -0,50 -0,53 6.25% | -0,50 -0,49 -3.09% | -0,50 -0,49 -2.04% | -0,40 -0,51 21.57% | -0,42 -0,44 3.82% | -0,37 -0,41 9.76% | -0,40 -0,40 -0.84% | -0,40 -0,40 -1.27% | -0,29 -0,22 -30.34% | -0,13 | -0,14 | -0,14 | -0,19 | -0,19 |
| Announcement Date | 12/05/22 | 11/08/22 | 10/11/22 | 23/03/23 | 11/05/23 | 08/08/23 | 09/11/23 | 21/03/24 | 09/05/24 | - | - | - | - | - |
More events
Past sector events for Regulus Therapeutics Inc.
| 2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 2024-05-15 04:01 pm | CELCUITY INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 08:00 am | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RGLS Stock
- Calendar Regulus Therapeutics Inc.
